Clinical Trial Update: Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial investigating whether short-term atorvastatin can improve vaccination efficacy in individuals who did not respond to the Hepatitis B vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Nematollah Jonaidi Jafari | Conditions: Hepatitis B, Vaccination Failure | Phase 4 | Status: UNKNOWN